查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386936

研究抗體市場報告：2030 年趨勢、預測與競爭分析

Research Antibodies Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

研究抗體趨勢和預測

到 2030 年，全球研究抗體市場預計將達到 55 億美元，2024 年至 2030 年複合年成長率為 6.5%。這個市場的主要驅動力是由於多發性硬化症和帕金森氏症的增加而對個人化醫療的需求不斷增加，以及新藥和蛋白質療法的開發。全球研究抗體市場的未來看起來充滿希望，免疫組織化學、螢光、西方印漬術、流式細胞儀、免疫沉澱和 ELISA 市場充滿機會。

研究抗體市場洞察

Lucintel預測單株抗體將用於發現和開發針對多種癌症類型的新治療方法，並且需要高選擇性抗體的癌症研究配合措施將會增加。此後，單株抗體在預測期內將繼續成為更大的區隔市場。

在這個市場中，免疫組織化學可能仍然是最大的部分，因為它在基於細胞的研究中檢測酶、抗原、腫瘤抑制基因和癌細胞增殖方面有廣泛的應用。

由於對幹細胞、醫學和癌症研究的興趣日益濃厚，以及對基於結構的藥物設計開發的投資增加，北美在預測期內可能仍是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球研究抗體市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球研究抗體市場趨勢（2018-2023）與預測（2024-2030）
  • 全球研究抗體市場（依產品）
    • 一抗
    • 二抗
  • 依類型分類的全球研究抗體市場
    • 單株抗體
    • 多克隆抗體
  • 依技術分類的全球研究抗體市場
    • 免疫組織化學
    • 螢光
    • 西方印漬術
    • 流式細胞儀
    • 免疫沉澱
    • ELISA
    • 其他
  • 全球研究抗體市場（依最終用途）
    • 學術研究所
    • 合約研究組織
    • 製藥和生物技術公司

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球研究抗體市場（依地區）
  • 北美研究抗體市場
  • 歐洲研究抗體市場
  • 亞太研究抗體市場
  • 其他區域研究抗體市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球研究抗體市場成長機會（依產品）
    • 依類型分類的全球研究抗體市場成長機會
    • 全球研究抗體市場成長機會（依技術）
    • 全球研究抗體市場成長機會（依最終用途）
    • 依地區分類的全球研究抗體市場成長機會
  • 全球研究抗體市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球研究抗體市場的產能
    • 全球研究抗體市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Abcam
  • Merck
  • Thermo Fisher Scientific
  • Cell Signalling Technology
  • Santa Cruz Biotechnology
  • PerkinElmer
  • Becton and Dickinson
簡介目錄

Research Antibodies Trends and Forecast

The future of the global research antibodies market looks promising with opportunities in the immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, and elisa markets. The global research antibodies market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing demand of personalized medicine and the development of novel drugs and protein therapeutics due to the growth in multiple sclerosis and parkinson's disease incidences.

A more than 150-page report is developed to help in your business decisions.

Research Antibodies by Segment

The study includes a forecast for the global research antibodies by product, type, technology, end use, and region.

Research Antibodies Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Primary Antibodies
  • Secondary Antibodies

Research Antibodies Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monoclonal Antibodies
  • Polyclonal Antibodies

Research Antibodies Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Immunohistochemistry
  • Munofluorescence
  • Western Blotting
  • Flow Cytometry
  • Immunoprecipitation
  • Elisa
  • Others

Research Antibodies Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Academic & Research Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies

Research Antibodies Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Research Antibodies Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies research antibodies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the research antibodies companies profiled in this report include-

  • Abcam
  • Merck
  • Thermo Fisher Scientific
  • Cell Signalling Technology
  • Santa Cruz Biotechnology
  • Perkinelmer
  • Becton and Dickinson

Research Antibodies Market Insights

Lucintel forecasts that monoclonal antibodies will remain the larger segment over the forecast period due to monoclonal antibodies uses in the discovery and development of new treatments for various cancer types and rise in the number of initiatives in cancer research that call for highly selective antibodies..

Within this market, immunohistochemistry will remain the largest segment due to its substantial applications in the detection of enzymes, antigens, tumor suppressor genes, and tumor cell proliferation for cell-based research.

North America will remain the largest region over the forecast period due to the growing focus on stem cells, biomedicine, and cancer research and rising investment in the development of structure-based drug designs in the region.

Features of the Global Research Antibodies Market

Market Size Estimates: Research antibodies market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Research antibodies market size by various segments, such as by product, type, technology, end use, and region in terms of value ($B).

Regional Analysis: Research antibodies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, technologies, end uses, and regions for the research antibodies market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the research antibodies market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the research antibodies market size?

Answer: The global research antibodies market is expected to reach an estimated $5.5 billion by 2030.

Q.2 What is the growth forecast for research antibodies market?

Answer: The global research antibodies market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the research antibodies market?

Answer: The major drivers for this market are increasing demand of personalized medicine and the development of novel drugs and protein therapeutics due to the growth in multiple sclerosis and parkinson's disease incidences.

Q4. What are the major segments for research antibodies market?

Answer: The future of the research antibodies market looks promising with opportunities in the immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, and elisa markets.

Q5. Who are the key research antibodies market companies?

Answer: Some of the key research antibodies companies are as follows:

  • Abcam
  • Merck
  • Thermo Fisher Scientific
  • Cell Signalling Technology
  • Santa Cruz Biotechnology
  • Perkinelmer
  • Becton and Dickinson

Q6. Which research antibodies market segment will be the largest in future?

Answer: Lucintel forecasts that monoclonal antibodies will remain the larger segment over the forecast period due to monoclonal antibodies uses in the discovery and development of new treatments for various cancer types and rise in the number of initiatives in cancer research that call for highly selective antibodies..

Q7. In research antibodies market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the growing focus on stem cells, biomedicine, and cancer research and rising investment in the development of structure-based drug designs in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the research antibodies market by product (primary antibodies and secondary antibodies), type (monoclonal antibodies and polyclonal antibodies), technology (immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, elisa, and others), end use (academic & research institutes, contract research organizations, and pharmaceutical & biotechnology companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Research Antibodies Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Research Antibodies Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Research Antibodies Market by Product
    • 3.3.1: Primary Antibodies
    • 3.3.2: Secondary Antibodies
  • 3.4: Global Research Antibodies Market by Type
    • 3.4.1: Monoclonal Antibodies
    • 3.4.2: Polyclonal Antibodies
  • 3.5: Global Research Antibodies Market by Technology
    • 3.5.1: Immunohistochemistry
    • 3.5.2: Munofluorescence
    • 3.5.3: Western Blotting
    • 3.5.4: Flow Cytometry
    • 3.5.5: Immunoprecipitation
    • 3.5.6: ELISA
    • 3.5.7: Others
  • 3.6: Global Research Antibodies Market by End Use
    • 3.6.1: Academic & Research Institutes
    • 3.6.2: Contract Research Organizations
    • 3.6.3: Pharmaceutical & Biotechnology Companies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Research Antibodies Market by Region
  • 4.2: North American Research Antibodies Market
    • 4.2.2: North American Research Antibodies Market by Technology: Immunohistochemistry, Munofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, and Others
  • 4.3: European Research Antibodies Market
    • 4.3.1: European Research Antibodies Market by Type: Monoclonal Antibodies and Polyclonal Antibodies
    • 4.3.2: European Research Antibodies Market by Technology: Immunohistochemistry, Munofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, and Others
  • 4.4: APAC Research Antibodies Market
    • 4.4.1: APAC Research Antibodies Market by Type: Monoclonal Antibodies and Polyclonal Antibodies
    • 4.4.2: APAC Research Antibodies Market by Technology: Immunohistochemistry, Munofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, and Others
  • 4.5: ROW Research Antibodies Market
    • 4.5.1: ROW Research Antibodies Market by Type: Monoclonal Antibodies and Polyclonal Antibodies
    • 4.5.2: ROW Research Antibodies Market by Technology: Immunohistochemistry, Munofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Research Antibodies Market by Product
    • 6.1.2: Growth Opportunities for the Global Research Antibodies Market by Type
    • 6.1.3: Growth Opportunities for the Global Research Antibodies Market by Technology
    • 6.1.4: Growth Opportunities for the Global Research Antibodies Market by End Use
    • 6.1.5: Growth Opportunities for the Global Research Antibodies Market by Region
  • 6.2: Emerging Trends in the Global Research Antibodies Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Research Antibodies Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Research Antibodies Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abcam
  • 7.2: Merck
  • 7.3: Thermo Fisher Scientific
  • 7.4: Cell Signalling Technology
  • 7.5: Santa Cruz Biotechnology
  • 7.6: PerkinElmer
  • 7.7: Becton and Dickinson